Breast Cancer Invasive

• FDA approval · 2018-06-27
  FDA Approved: EVISTA — Supplemental Application (Eli Lilly and Company)

  The FDA approved a supplemental application for EVISTA (raloxifene hydrochloride) by Eli Lilly. The action updates the labeling with a new o…

• FDA approval · 2016-04-08
  FDA Approved: RALOXIFENE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approved the original application for raloxifene hydrochloride (Amneal Pharmaceuticals LLC) as a generic, for postmenopausal osteoporosi…